$ABBV
ABBVIE INC.
XNYS•Health Care•Pharmaceutical Preparations
$276.47
▲+1.49%+$4.05
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is ABBV up today? It is at $276.47 (+1.49%), and our scanner flagged it 64 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ABBV spikes, and full due diligence on ABBV — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ABBV 64 times in the last 30 days. Create a free account to track $ABBV, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ABBV from our scanner (live price and day move above). A recent catalyst in the news: “A Stock Market Crash Is Coming By the End of 2027, According to Some Economists. Here Are 2 Stocks to Buy Before That Happens.” Early read: bullish.
Likely catalystGuidance Including the Impact of Acquired IPR&D and Milestones Expense, from the latest SEC filing. Read it →A share sale has already completed, so that supply is out there. Size not stated in the filing.
Some filings did not state a size, so these are floors.
Recent priced share offering — a one-time sale that has already completed (not ongoing)
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From SEC 13F quarterly holdings (position as of quarter-end, not a transaction date or price) and dated 13D/13G stake filings. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Donoghoe Nicholas Officer | Sold (automatic/other) | -33K | sold 31% | 74K | $8.2M at $250.00 | Aug 14, 26 |
Donoghoe Nicholas Officer | Other | 33K | added 44% | 107K | $2.6M at $79.02 | Aug 14, 26 |
Austin Roxanne S Director | Acquired (grant/award) | +1K | added 2.9% | 40K | n/a | May 8, 26 |
Burnside William H.L. Director | Acquired (grant/award) | +1K | added 4.1% | 28K | n/a | May 8, 26 |
Davis Jennifer L. Director | Acquired (grant/award) | +1K | added 44% | 4K | n/a | May 8, 26 |
Hart Brett J Director | Acquired (grant/award) | +1K | added 5.7% | 21K | n/a | May 8, 26 |
Roberts Rebecca B Director | Acquired (grant/award) | +1K | added 8.1% | 15K | n/a | May 8, 26 |
Waddell Frederick H Director | Acquired (grant/award) | +1K | added 3.9% | 30K | n/a | May 8, 26 |
Meyer Melody B Director | Acquired (grant/award) | +1K | added 6.8% | 18K | n/a | May 8, 26 |
Freyman Thomas C Director | Acquired (grant/award) | +1K | added 0.9% | 128K | n/a | May 8, 26 |
Rapp Edward J Director | Acquired (grant/award) | +1K | added 2.5% | 46K | n/a | May 8, 26 |
Quaggin Susan E Director | Acquired (grant/award) | +1K | added 44% | 4K | n/a | May 8, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Curated groups ABBV belongs to. Tap one to see every member with today's move and why the group is moving.
Here is the latest on ABBV from our scanner (live price and day move above). A recent catalyst in the news: “A Stock Market Crash Is Coming By the End of 2027, According to Some Economists. Here Are 2 Stocks to Buy Before That Happens.” Early read: bullish.
ABBV last traded at $276.47, up 1.49% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
ABBVIE INC. (ABBV) is next expected to report earnings on Friday, October 30, 2026 (before open), about 20 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
Yes. ABBV currently has a dividend yield of about 2.50% ($6.92 per share per year), with the next ex-dividend date on Oct 15. Dividend figures can change; this is not investment advice.
The ABBV Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ABBV 64 times in the last 30 days.
ABBV (ABBVIE INC.) trades on XNYS, with a market cap of about $488.55B in the PHARMACEUTICAL PREPARATIONS sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ABBV for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ABBV discussion
Sign in to ask a question or join the discussion.